Nutrition and MS: What’s the deal with wheat?
The topic of nutrition is a perennial issue in Multiple Sclerosis. Of course, we all have to eat – and the idea that the things we consume on a daily basis have an impact on
Continue reading
Deaths Associated with Pregabalin
Currently, reports from the UK are causing a stir. The reason is data from the British statistical authority, according to which there have been increasing deaths in connection with the intake of Pregabalin from 2018
Continue reading
Tyruko® – the new Natalizumab Biosimilar
Since some time ago, several oral MS drugs have been available as generics (see also MS-DocBlog Generics in MS therapy), since February 01, 2024, Tyruko® from Sandoz is also the first biosimilar approved and available
Continue reading
Cancellation of Homeopathy as a Health Insurance Benefit
I am not a particular fan of the policies of Health Minister Karl Lauterbach, but he is right with the measure to remove homeopathy from health insurance benefits – even if he is accused of
Continue readingConsiderations on the Placebo Effect
The discussion about my text on the Mollii Suit at the end of last year was interesting. After the publication of the text, some of my patients approached me and showed me videos of their
Continue reading
Outlook 2024: CAR-T Cell Therapy
I would like to wish all my readers a happy, joyful and above all healthy new year 2024. At the beginning of a year, one is sometimes asked where one sees interesting potentials in terms
Continue reading
Merry Christmas and a Happy New Year
The year 2023 is slowly coming to an end. Therefore, as usual at this point, I would like to wish my readers a blessed Christmas season, as well as luck and health for the coming
Continue reading
Diagnosis Transmission MS – Initial Speech
On the initiative of the Federal Advisory Board for MS Patients (BBMSE), the DMSG recently issued a flyer providing doctors with “tips” for diagnosing multiple sclerosis: recommendations such as “take your time for the patient”
Continue reading
Autologous Hematopoietic Stem Cell Transplantation (aHSCT) – Results from the Swedish MS Registry
In September 2023, a paper from Sweden was published in the Journal of Neurology Neurosurgery and Psychiatry (JNNP) (Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study |
Continue readingExopulse Mollii Suit – not like this …
Recently, the DMSG Federal Association has been receiving an increasing number of inquiries from MS patients regarding the possibility of reimbursement for the Exopulse Mollii Suit by statutory health insurance companies, as well as by
Continue reading
